FIELD: veterinary medicine.
SUBSTANCE: medication for the prevention and treatment of Pathology findings in animals contains 3.0-5.0 mas.% of phenyl-tert-butilnitrona, 1.0-2.0 mas.% β-carotene, 7.5-10.5 mas.% 2.6-ditretbutil-4-nonylphenol, 10.0-15.0 mas.% of 2,4,6,8-tetramethyl-2,4,6,8-tetraazabicyclo-(3,3,0)-oktadyselenon-3.7, 5.0-9.0 mas.% Solutol HS15, 0.2-0.4 mas.% Polyvinylpyrrolidone and water for injection (the rest).
EFFECT: increasing the stress resistance of the organism, reducing toxicity and increased ease of use and dosage.
dwg 6 7 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOSTIMULATING MEDICATION FOR SELENIUM EXCHANGE NORMALISATION AND CORRECTION OF STRESS STATES FOR AGRICULTURAL ANIMALS | 2010 |
|
RU2418579C1 |
ANTIOXIDANT PREPARATION FOR ANIMALS | 2010 |
|
RU2435572C1 |
ANTIOXIDANT ANTI-INFLAMMATORY PREPARATION FOR ANIMALS | 2018 |
|
RU2686462C1 |
PREPARATION FOR NORMALISATION OF LIPID PEROXIDATION PROCESSES IN ANIMALS | 2013 |
|
RU2538666C2 |
PREPARATION FOR PREVENTING AND TREATING INFLAMMATORY PROCESSES IN ANIMALS | 2019 |
|
RU2725773C1 |
AGENT POSSESSING ANTIRADICAL, CEREBROPROTECTIVE AND ANTIISCHEMIC PROPERTIES | 2010 |
|
RU2445090C1 |
ANTIOXIDANT PREPARATION FOR TREATMENT AND PREVENTION OF CARDIAC PATHOLOGIES IN ANIMALS | 2023 |
|
RU2818764C1 |
METHOD OF ANIMAL OXIDATIVE STRESS TREATMENT AND PREVENTION | 2007 |
|
RU2329793C1 |
ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
ANTIOXIDANT PREPARATION FOR TREATING AND PREVENTING NEUROLOGICAL PATHOLOGIES IN ANIMALS | 2023 |
|
RU2813928C1 |
Authors
Dates
2017-05-15—Published
2016-02-24—Filed